Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study

Jorge E. Cortes; Jeff H. Lipton; Vamsi Kota; Fausto Castagnetti; Sarit Assouline; Tim H. Brümmendorf; Eric Leip; Andrea Viqueira; Carlo Gambacorti-Passerini

doi:10.3324/haematol.2022.281944

Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study

Jorge E. Cortes, Jeff H. Lipton, Vamsi Kota, Fausto Castagnetti, Sarit Assouline, Tim H. Brümmendorf, Eric Leip, Andrea Viqueira, Carlo Gambacorti-Passerini

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	3454-3459
Number of pages	6
Journal	Haematologica
Volume	108
Issue number	12
DOIs	https://doi.org/10.3324/haematol.2022.281944
State	Published - Dec 2023

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2022.281944

Cite this

Cortes, J. E., Lipton, J. H., Kota, V., Castagnetti, F., Assouline, S., Brümmendorf, T. H., Leip, E., Viqueira, A., & Gambacorti-Passerini, C. (2023). Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study. Haematologica, 108(12), 3454-3459. https://doi.org/10.3324/haematol.2022.281944

Cortes, JE, Lipton, JH, Kota, V, Castagnetti, F, Assouline, S, Brümmendorf, TH, Leip, E, Viqueira, A & Gambacorti-Passerini, C 2023, 'Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study', Haematologica, vol. 108, no. 12, pp. 3454-3459. https://doi.org/10.3324/haematol.2022.281944

@article{1228280183f04dbcaa1b6c7cbfc635cf,

title = "Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study",

author = "Cortes, {Jorge E.} and Lipton, {Jeff H.} and Vamsi Kota and Fausto Castagnetti and Sarit Assouline and Br{\"u}mmendorf, {Tim H.} and Eric Leip and Andrea Viqueira and Carlo Gambacorti-Passerini",

year = "2023",

month = dec,

doi = "10.3324/haematol.2022.281944",

language = "English (US)",

volume = "108",

pages = "3454--3459",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "12",

}

TY - JOUR

T1 - Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia

T2 - long-term analysis of a phase I/II study

AU - Cortes, Jorge E.

AU - Lipton, Jeff H.

AU - Kota, Vamsi

AU - Castagnetti, Fausto

AU - Assouline, Sarit

AU - Brümmendorf, Tim H.

AU - Leip, Eric

AU - Viqueira, Andrea

AU - Gambacorti-Passerini, Carlo

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85178651976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85178651976&partnerID=8YFLogxK

U2 - 10.3324/haematol.2022.281944

DO - 10.3324/haematol.2022.281944

M3 - Letter

C2 - 37439348

AN - SCOPUS:85178651976

SN - 0390-6078

VL - 108

SP - 3454

EP - 3459

JO - Haematologica

JF - Haematologica

IS - 12

ER -

Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this